Section 1115 waivers are meant to be experiments that allow states to test coverage approaches that don’t meet federal program rules. However, most of their evaluations are not rigorously studied, argues a new commentary in the New England Journal of Medicine.
Medicaid demonstrations aren’t properly evaluated. Randomized trials could fix that
